GSK champions erosive tooth wear and Dentine Hypersensitivity identification
GSK is leading a campaign to raise awareness among dentists, DCPs and patients about two common conditions – erosive tooth wear and Dentine Hypersensitivity (DH).
Over ¾ of British adults - 77% exhibit signs of tooth wear and moderate tooth wear has increased1. It can lead to changes in tooth shape, yellowing of teeth and translucency at the tooth edge. You can now download the BEWE app for a comprehensive guide to erosive tooth wear diagnosis and condition management.
The optimised fluoride formulation of Pronamel® strengthens your patients’ demineralised enamel to help protect against the effects of erosive tooth wear2.
DH is characterised by short, sharp pain in response to stimuli and needs to be diagnosed differentially. 41.9% of adults have experienced it3 and, according to the Dentine Hypersensitivity Experience Questionnaire (DHEQ), over 70% of sufferers consider the sensations to take pleasure out of eating and drinking4.
Sensodyne® Repair and Protect combines NovaMin® technology and sodium fluoride in a single formulation, which creates an even harder hydroxyapatite-like layer over the exposed dentine and within the exposed dentine tubules2, 5-7, providing sustained protection and relief.
For more information on these conditions and other CPD materials, visit: https://www.gsk-dentalprofessionals.co.uk/
Trade marks are owned by or licensed to the GSK group of companies.
CHGBI/CHSEN/0023/16
References:
1. Disease and related disorders – a report from the Adult Dental Health Survey 2009, The Information Centre for health and social care, 2011
2. Fowler C et al J Clin Dent 2006; 17(4): 100 - 105
3. Addy M. Int Dent J 2002; 52: 367-375.
4. GSK Data on File RH02026
5. Greenspan DC et al. J Clin Dent 2010; 21: 61-65.
6. La Torre G and Greenspan DC. J Clin Dent 2010; 21(Spec Iss): 72-76.
7. Earl JS et al. J Clin Dent 2011; 22(3): 62-67(A).
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.